Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from Japan.

Hiroyuki AdachiAya SaitoYasushi ShintaniJiro OkamiHiroyuki ItoTakashi OhtsukaTakeshi MoriShun-Ichi WatanabeMasayuki ChidaShunsuke EndoRyoichi NakanishiMitsutaka KadokuraHidemi SuzukiEtsuo MiyaokaIchiro YoshinoHiroshi Datenull null

Published in: Japanese journal of clinical oncology (2023)

adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer showed no benefit for recommendation for elderly patients; considering the risk of adverse events, we do not recommend adjuvant chemotherapy for elderly patients.

Keyphrases

prognostic factors
machine learning